BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

17 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Polypeptide compound, pharmaceutical composition, preparation method and application thereofBDB
Chengdu Sintanovo Biotechnology
Amide substituted indole compounds useful as TLR inhibitorsBDB
Bristol-Myers Squibb
Fluorinated lysyl oxidase-like 2 inhibitors and uses thereofBDB
Pharmakea
Pyrimidine derivative, method for preparing same and use thereof in medicineBDB
TBA
5-[3-[piperazin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 4 and 5 inhibitors for treating e.g. osteoarthritisBDB
Galapagos
Combination of respiratory electron transport chain inhibitors with a cytochrome bd inhibitorBDB
TBA
Methods and compositions for cell-proliferation-related disordersBDB
Agios Pharmaceuticals
Chemical compoundsBDB
Astrazeneca
Carboxamide derivativesBDB
Novartis
Synthesis, inhibitory activity and molecular docking studies of two Cu(II) complexes against Helicobacter pylori urease.BDB
Wuhan Textile University
Potent poxvirus inhibitorBDB
University of Pennsylvania
Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapyBDB
Abbvie
Discovery of a Selective Covalent Inhibitor of Lysophospholipase-like 1 (LYPLAL1) as a Tool to Evaluate the Role of this Serine Hydrolase in Metabolism.BDB
Pfizer
Pyrazolopyrimidines Establish MurC as a Vulnerable Target in Pseudomonas aeruginosa and Escherichia coli.BDB
Astrazeneca India
Inhibitors of C-FMS kinaseBDB
Janssen Pharmaceutica
 
Design, synthesis, and biological evaluation of new 3-hydroxy-2-oxo-3-trifluoromethylindole as potential HIV-1 reverse transcriptase inhibitorsBDB
Instituto De Tecnologia Em Fa��Rmacos